ACB: Record medical cannabis revenue and EBITDA, with focus shifting to global medical markets
June 11, 2026
ACBRecord annual medical cannabis revenue and adjusted EBITDA were achieved, driven by strong international growth and strategic acquisitions. The outlook anticipates lower revenue and EBITDA due to Canadian pricing changes, with a continued focus on global medical markets.
Original document: Aurora Cannabis Inc. [ACB] Earnings Release — Jun. 11 2026
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
© AI-generated summary is provided by Quartr
Search
RECENT PRESS RELEASES
Related Post
